• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微小 RNA-1236 通过抑制 VEGFR-3 信号通路抑制炎症性淋巴管生成。

Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.

机构信息

Interdepartmental Program in Vascular Biology and Therapeutics, Department of Immunobiology, Yale University School of Medicine, 10 Amistad St., New Haven, CT 06520, USA.

出版信息

Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):633-42. doi: 10.1161/ATVBAHA.111.243576. Epub 2012 Jan 5.

DOI:10.1161/ATVBAHA.111.243576
PMID:22223733
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3288963/
Abstract

OBJECTIVE

Vascular endothelial growth factor receptor(VEGFR)-3 is a critical regulator of developmental and adult vasculogenesis and lymphangiogenesis through its interactions with select members of the VEGF family. The goal of this study was to investigate how VEGFR-3 expression is regulated during inflammatory lymphangiogenesis.

METHODS AND RESULTS

In this study, we present for the first time evidence that VEGFR-3 can be negatively regulated by a mirtron, hsa-miR-1236 (miR-1236), which is expressed in primary human lymphatic endothelial cells. In human lymphatic endothelial cells, miR-1236 is upregulated in response to IL-1β, a negative regulator of VEGFR-3. miR-1236 binds the 3' untranslated region of Vegfr3, resulting in translational inhibition. Overexpression of miR-1236 significantly decreased expression of VEGFR-3, but not VEGFR-2, in human lymphatic endothelial cells. Compared to a control miR, overexpression of miR-1236 also led to decreased VEGFR-3 signaling. However, VEGFR-2-specific signaling was not affected. miR-1236 can attenuate human lymphatic endothelial cell migration and tube formation, as well as in vivo lymphangiogenesis.

CONCLUSION

Our data suggest that miR-1236 may function as a negative regulator of VEGFR-3 signaling during inflammatory lymphangiogenesis.

摘要

目的

血管内皮生长因子受体(VEGFR)-3 通过与 VEGF 家族的特定成员相互作用,成为发育和成人血管生成和淋巴管生成的关键调节因子。本研究的目的是研究 VEGFR-3 在炎症性淋巴管生成过程中的表达是如何被调节的。

方法和结果

在这项研究中,我们首次提出证据表明,miR-1236(miR-1236)可以负调控 VEGFR-3,miR-1236 是在原代人淋巴管内皮细胞中表达的 mirtron。在人淋巴管内皮细胞中,miR-1236 在内毒素β(IL-1β)的刺激下上调,IL-1β 是 VEGFR-3 的负调控因子。miR-1236 结合 Vegfr3 的 3'非翻译区,导致翻译抑制。miR-1236 的过表达显著降低了人淋巴管内皮细胞中 VEGFR-3 的表达,但不降低 VEGFR-2 的表达。与对照 miR 相比,miR-1236 的过表达也导致 VEGFR-3 信号转导减少。然而,VEGFR-2 特异性信号转导不受影响。miR-1236 可减弱人淋巴管内皮细胞的迁移和管形成,以及体内淋巴管生成。

结论

我们的数据表明,miR-1236 可能在炎症性淋巴管生成过程中作为 VEGFR-3 信号的负调节剂发挥作用。

相似文献

1
Mirtron microRNA-1236 inhibits VEGFR-3 signaling during inflammatory lymphangiogenesis.微小 RNA-1236 通过抑制 VEGFR-3 信号通路抑制炎症性淋巴管生成。
Arterioscler Thromb Vasc Biol. 2012 Mar;32(3):633-42. doi: 10.1161/ATVBAHA.111.243576. Epub 2012 Jan 5.
2
Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.可溶性血管内皮生长因子受体-2在小鼠肺癌模型中对淋巴管生成的抑制作用
Biomed Pharmacother. 2016 Dec;84:660-665. doi: 10.1016/j.biopha.2016.09.083. Epub 2016 Sep 30.
3
uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.uPARAP/Endo180 受体是病理性淋巴管生成过程中 VEGFR-2/VEGFR-3 异二聚体形成的守门员。
Nat Commun. 2018 Dec 5;9(1):5178. doi: 10.1038/s41467-018-07514-1.
4
Differential Receptor Binding and Regulatory Mechanisms for the Lymphangiogenic Growth Factors Vascular Endothelial Growth Factor (VEGF)-C and -D.淋巴管生成生长因子血管内皮生长因子(VEGF)-C和-D的差异受体结合及调控机制
J Biol Chem. 2016 Dec 30;291(53):27265-27278. doi: 10.1074/jbc.M116.736801. Epub 2016 Nov 16.
5
Molecular controls of lymphatic VEGFR3 signaling.淋巴管内皮 VEGFR3 信号的分子调控
Arterioscler Thromb Vasc Biol. 2015 Feb;35(2):421-9. doi: 10.1161/ATVBAHA.114.304881. Epub 2014 Dec 18.
6
Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.舒尼替尼通过抑制血管内皮生长因子受体 3 抑制乳腺癌模型中的淋巴管内皮细胞功能和淋巴结转移。
Breast Cancer Res. 2011 Jun 21;13(3):R66. doi: 10.1186/bcr2903.
7
Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.在血管内皮生长因子诱导的淋巴管生成中,对 X 染色体上骨髓激酶的功能分析。
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2553-61. doi: 10.1161/ATVBAHA.110.214999. Epub 2010 Sep 23.
8
Inflammation induces lymphangiogenesis through up-regulation of VEGFR-3 mediated by NF-kappaB and Prox1.炎症通过 NF-κB 和 Prox1 介导的 VEGFR-3 的上调诱导淋巴管生成。
Blood. 2010 Jan 14;115(2):418-29. doi: 10.1182/blood-2008-12-196840. Epub 2009 Nov 9.
9
Lymphangiogenesis in aortic valve stenosis--novel regulatory roles for valvular myofibroblasts and mast cells.主动脉瓣狭窄中的淋巴管生成——瓣膜成纤维细胞和肥大细胞的新调节作用。
Atherosclerosis. 2012 Apr;221(2):366-74. doi: 10.1016/j.atherosclerosis.2011.12.034. Epub 2011 Dec 29.
10
VEGF-A expression by HSV-1-infected cells drives corneal lymphangiogenesis.单纯疱疹病毒 1 感染细胞表达血管内皮生长因子-A 可驱动角膜淋巴管生成。
J Exp Med. 2010 Jan 18;207(1):101-15. doi: 10.1084/jem.20091385. Epub 2009 Dec 21.

引用本文的文献

1
Mirtrons in Human Cancers.人类癌症中的微小内含子。
Onco (Basel). 2025 Mar;5(1). doi: 10.3390/onco5010007. Epub 2025 Feb 8.
2
miR-1236-3p targets Toll-like receptor 4 to suppress the anti- activity of macrophage.微小RNA-1236-3p靶向Toll样受体4以抑制巨噬细胞的抗炎活性。
iScience. 2025 May 8;28(6):112522. doi: 10.1016/j.isci.2025.112522. eCollection 2025 Jun 20.
3
Rosuvastatin Enhances Lymphangiogenesis after Myocardial Infarction by Regulating the miRNAs/Vascular Endothelial Growth Factor Receptor 3 (miRNAs/VEGFR3) Pathway.瑞舒伐他汀通过调节miRNAs/血管内皮生长因子受体3(miRNAs/VEGFR3)通路促进心肌梗死后的淋巴管生成。
ACS Pharmacol Transl Sci. 2024 Feb 1;7(2):335-347. doi: 10.1021/acsptsci.3c00151. eCollection 2024 Feb 9.
4
Dysregulation of Lymphatic Endothelial VEGFR3 Signaling in Disease.淋巴管内皮 VEGFR3 信号失调与疾病
Cells. 2023 Dec 28;13(1):68. doi: 10.3390/cells13010068.
5
Molecular and metabolic orchestration of the lymphatic vasculature in physiology and pathology.淋巴血管系统在生理和病理中的分子和代谢调控。
Nat Commun. 2023 Dec 16;14(1):8389. doi: 10.1038/s41467-023-44133-x.
6
Circular RNA_0001187 participates in the regulation of ulcerative colitis development via upregulating myeloid differentiation factor 88.环状 RNA_0001187 通过上调髓样分化因子 88 参与溃疡性结肠炎的发展调控。
Bioengineered. 2022 May;13(5):12863-12875. doi: 10.1080/21655979.2022.2077572.
7
Non-canonical features of microRNAs: paradigms emerging from cardiovascular disease.非典型 microRNA 特征:心血管疾病中的新兴范例。
Nat Rev Cardiol. 2022 Sep;19(9):620-638. doi: 10.1038/s41569-022-00680-2. Epub 2022 Mar 18.
8
Crosstalk Between microRNAs and the Pathological Features of Secondary Lymphedema.微小RNA与继发性淋巴水肿病理特征之间的相互作用
Front Cell Dev Biol. 2021 Oct 18;9:732415. doi: 10.3389/fcell.2021.732415. eCollection 2021.
9
CCM3 Loss-Induced Lymphatic Defect Is Mediated by the Augmented VEGFR3-ERK1/2 Signaling.CCM3 缺失诱导的淋巴管缺陷是由增强的 VEGFR3-ERK1/2 信号介导的。
Arterioscler Thromb Vasc Biol. 2021 Dec;41(12):2943-2960. doi: 10.1161/ATVBAHA.121.316707. Epub 2021 Oct 21.
10
Inflammatory state of lymphatic vessels and miRNA profiles associated with relapse in ovarian cancer patients.淋巴管的炎症状态和与卵巢癌患者复发相关的 miRNA 谱。
PLoS One. 2020 Jul 27;15(7):e0230092. doi: 10.1371/journal.pone.0230092. eCollection 2020.

本文引用的文献

1
An overview of lymphatic vessels and their emerging role in cardiovascular disease.淋巴管概述及其在心血管疾病中的新作用。
J Cardiovasc Dis Res. 2011 Jul;2(3):141-52. doi: 10.4103/0975-3583.85260.
2
MicroRNA-16 and microRNA-424 regulate cell-autonomous angiogenic functions in endothelial cells via targeting vascular endothelial growth factor receptor-2 and fibroblast growth factor receptor-1.MicroRNA-16 和 microRNA-424 通过靶向血管内皮生长因子受体-2 和成纤维细胞生长因子受体-1 调节内皮细胞中的细胞自主血管生成功能。
Arterioscler Thromb Vasc Biol. 2011 Nov;31(11):2595-606. doi: 10.1161/ATVBAHA.111.236521.
3
Tissue inflammation modulates gene expression of lymphatic endothelial cells and dendritic cell migration in a stimulus-dependent manner.组织炎症以刺激依赖的方式调节淋巴管内皮细胞和树突状细胞迁移的基因表达。
Blood. 2011 Jul 7;118(1):205-15. doi: 10.1182/blood-2010-12-326447. Epub 2011 May 19.
4
An important role of lymphatic vessel activation in limiting acute inflammation.淋巴管激活在限制急性炎症中起着重要作用。
Blood. 2011 Apr 28;117(17):4667-78. doi: 10.1182/blood-2010-10-316356. Epub 2011 Mar 1.
5
T lymphocytes negatively regulate lymph node lymphatic vessel formation.T 淋巴细胞负向调控淋巴结淋巴管的形成。
Immunity. 2011 Jan 28;34(1):96-107. doi: 10.1016/j.immuni.2010.12.016. Epub 2011 Jan 20.
6
Interleukin-1β expression is required for lysophosphatidic Acid-induced lymphangiogenesis in human umbilical vein endothelial cells.白细胞介素-1β的表达是溶血磷脂酸诱导人脐静脉内皮细胞淋巴管生成所必需的。
Int J Inflam. 2010 Aug 4;2011:351010. doi: 10.4061/2011/351010.
7
Functional analyses of the bone marrow kinase in the X chromosome in vascular endothelial growth factor-induced lymphangiogenesis.在血管内皮生长因子诱导的淋巴管生成中,对 X 染色体上骨髓激酶的功能分析。
Arterioscler Thromb Vasc Biol. 2010 Dec;30(12):2553-61. doi: 10.1161/ATVBAHA.110.214999. Epub 2010 Sep 23.
8
Prox1 expression is negatively regulated by miR-181 in endothelial cells.Prox1 的表达在血管内皮细胞中受到 miR-181 的负调控。
Blood. 2010 Sep 30;116(13):2395-401. doi: 10.1182/blood-2009-12-256297. Epub 2010 Jun 17.
9
The mouse retina as an angiogenesis model.鼠视网膜作为血管生成模型。
Invest Ophthalmol Vis Sci. 2010 Jun;51(6):2813-26. doi: 10.1167/iovs.10-5176.
10
miR-31 functions as a negative regulator of lymphatic vascular lineage-specific differentiation in vitro and vascular development in vivo.miR-31 在体外作为淋巴管谱系特异性分化的负调节剂,在体内作为血管发育的负调节剂。
Mol Cell Biol. 2010 Jul;30(14):3620-34. doi: 10.1128/MCB.00185-10. Epub 2010 May 17.